{"id":"para-aminosalicylic-acid","safety":{"commonSideEffects":[{"rate":"null","effect":"Gastrointestinal disturbances"},{"rate":"null","effect":"Neurological effects"}]},"_chembl":{"chemblId":"CHEMBL1169","moleculeType":"Small molecule","molecularWeight":"153.14"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"It does this by competitively inhibiting the enzyme dihydropteroate synthetase, which is necessary for the synthesis of tetrahydrofolate. This action prevents the bacteria from producing the necessary nucleotides for DNA synthesis and replication, ultimately leading to the inhibition of bacterial growth.","oneSentence":"Para-Aminosalicylic Acid is a bacteriostatic antibiotic that inhibits the synthesis of folate in bacteria.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:25:29.368Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Tuberculosis"}]},"trialDetails":[{"nctId":"NCT05213234","phase":"NA","title":"Chronotherapy of 5-Aminosalicylic Acid in Ulcerative Colitis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Rush University Medical Center","startDate":"2021-07-09","conditions":"Ulcerative Colitis","enrollment":32},{"nctId":"NCT05986136","phase":"PHASE2, PHASE3","title":"Activation of Autophagy and Suppression of Apoptosis by Dapagliflozin Attenuates Inflammatory Bowel Disease","status":"RECRUITING","sponsor":"Mostafa Bahaa","startDate":"2023-08-20","conditions":"Inflammatory Bowel Diseases","enrollment":50},{"nctId":"NCT07389824","phase":"NA","title":"Efficacy of Acupuncture-Mesalazine Combination Therapy in Ulcerative Colitis.","status":"NOT_YET_RECRUITING","sponsor":"Qin Yu","startDate":"2026-02-01","conditions":"Ulcerative Colitis","enrollment":80},{"nctId":"NCT07296315","phase":"PHASE2","title":"Confirmatory Clinical Study in Active Ulcerative Colitis","status":"NOT_YET_RECRUITING","sponsor":"MRM Health NV","startDate":"2026-03","conditions":"Colitis, Ulcerative","enrollment":204},{"nctId":"NCT00042289","phase":"","title":"Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2003-06-09","conditions":"HIV Infections","enrollment":1578},{"nctId":"NCT06998693","phase":"","title":"A Single-Center Observational Study on the Impact of Symptom Assessment Timing on the Short-Term Efficacy of 5-ASA Therapy in Patients With Initial-Onset or Relapsed Mild-to-Moderate Active Ulcerative Colitis","status":"COMPLETED","sponsor":"Xijing Hospital of Digestive Diseases","startDate":"2024-08-01","conditions":"Ul","enrollment":180},{"nctId":"NCT06201793","phase":"PHASE2","title":"Minocyclin in Ulcerative Colitis as Added on Therapy","status":"COMPLETED","sponsor":"Mostafa Bahaa","startDate":"2024-01-22","conditions":"Inflammatory Bowel Diseases","enrollment":46},{"nctId":"NCT05988528","phase":"PHASE2, PHASE3","title":"Clinical Study to Evaluate the Possible Efficacy of Nifuroxazide in Patient With Ulcerative Colitis","status":"COMPLETED","sponsor":"Mostafa Bahaa","startDate":"2023-08-20","conditions":"Inflammatory Bowel Diseases","enrollment":50},{"nctId":"NCT05610956","phase":"EARLY_PHASE1","title":"Evaluate the Possible Efficacy and Safety of Empagliflozin in Patient With Ulcerative Colitis","status":"RECRUITING","sponsor":"Tanta University","startDate":"2023-01-01","conditions":"Ulcerative Colitis","enrollment":60},{"nctId":"NCT05663775","phase":"PHASE2","title":"Prophylactic Mesalamine to Prevent Colitis Following Treatment With Ipilimumab/Nivolumab (Ipi/Nivo)","status":"RECRUITING","sponsor":"AHS Cancer Control Alberta","startDate":"2024-08-20","conditions":"Immune-related Adverse Event, Diarrhea, Advanced Melanoma","enrollment":20},{"nctId":"NCT06895252","phase":"NA","title":"A Study to Evaluate the Effect of Fecal Transplant and Dietary Changes on Disease Activity in Patients With Newly Diagnosed Active Ulcerative Colitis","status":"RECRUITING","sponsor":"All India Institute of Medical Sciences","startDate":"2025-03-15","conditions":"Ulcerative Colitis (UC)","enrollment":220},{"nctId":"NCT06081361","phase":"PHASE3","title":"Innovating Shorter, All- Oral, Precised, Individualized Treatment Regimen for Rifampicin Resistant Tuberculosis：Contezolid, Delamanid and Bedaquiline Cohort","status":"ACTIVE_NOT_RECRUITING","sponsor":"Beijing Chest Hospital","startDate":"2023-12-22","conditions":"Pulmonary Tuberculosis, Rifampicin-resistant Tuberculosis","enrollment":186},{"nctId":"NCT06213857","phase":"PHASE2","title":"Beneficial Effect of Silymarin in Ulcerative Colitis","status":"RECRUITING","sponsor":"Tanta University","startDate":"2025-02-01","conditions":"Ulcerative Colitis","enrollment":44},{"nctId":"NCT02365623","phase":"PHASE2","title":"An Exploratory Study of TMC207 in Japanese Participants With Pulmonary Multi-Drug Resistant Tuberculosis (MDR-TB)","status":"COMPLETED","sponsor":"Janssen Pharmaceutical K.K.","startDate":"2015-02-18","conditions":"Tuberculosis, Multidrug-Resistant","enrollment":6},{"nctId":"NCT03237182","phase":"PHASE4","title":"The Individualized M(X) Drug-resistant TB Treatment Strategy Study","status":"TERMINATED","sponsor":"Centre for the AIDS Programme of Research in South Africa","startDate":"2017-06-14","conditions":"Tuberculosis, Multidrug-Resistant","enrollment":205},{"nctId":"NCT06013696","phase":"NA","title":"Bleach and Urine Color in UC Patients Using 5ASA","status":"UNKNOWN","sponsor":"Meir Medical Center","startDate":"2023-07-16","conditions":"Ulcerative Colitis","enrollment":40},{"nctId":"NCT02537210","phase":"NA","title":"Aminosalicylic Acid Withdrawal Study in Long Standing Inactive Ulcerative Colitis","status":"COMPLETED","sponsor":"Chinese University of Hong Kong","startDate":"2015-09","conditions":"Colitis, Ulcerative, Aminosalicylic Acid","enrollment":177},{"nctId":"NCT04499495","phase":"","title":"Assessment of 5-Aminosalicylic Acid Prescription Patterns and Treatment Outcomes in Patients With Ulcerative Colitis in Korea","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2021-10-25","conditions":"Ulcerative Colitis","enrollment":11385},{"nctId":"NCT03980405","phase":"NA","title":"Combination of Diet and 5ASA ( 5-aminosalicylic Acid) for Ulcerative Colitis","status":"TERMINATED","sponsor":"Prof. Arie Levine","startDate":"2020-04-01","conditions":"Ulcerative Colitis","enrollment":12},{"nctId":"NCT01941589","phase":"PHASE4","title":"Corticosteroids+5-aminosalicylic Acid Compared to Corticosteroids in the Treatment of Moderate-severe Ulcerative Colitis","status":"COMPLETED","sponsor":"Sheba Medical Center","startDate":"2013-09","conditions":"Ulcerative Colitis","enrollment":149},{"nctId":"NCT00000796","phase":"NA","title":"A Prospective Study of Multidrug Resistance and a Pilot Study of the Safety of and Clinical and Microbiologic Response to Levofloxacin in Combination With Other Antimycobacterial Drugs for Treatment of Multidrug-Resistant Pulmonary Tuberculosis (MDRTB) in HIV-Infected Patients.","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"HIV Infections, Tuberculosis","enrollment":525},{"nctId":"NCT02930343","phase":"PHASE3","title":"Comparison of Disease Modifying Antirheumatic Drugs Therapy in Patients With RA Failing Methotrexate Monotherapy","status":"TERMINATED","sponsor":"Jawaharlal Institute of Postgraduate Medical Education & Research","startDate":"2016-09","conditions":"Rheumatoid Arthritis","enrollment":136},{"nctId":"NCT04032652","phase":"PHASE2","title":"Use of Rectal Dialysis Technique to Measure Rectal 5-ASA Levels in Healthy Volunteers Receiving Asacol","status":"TERMINATED","sponsor":"Endeavor Health","startDate":"2012-12","conditions":"Ulcerative Colitis","enrollment":2},{"nctId":"NCT01532648","phase":"PHASE3","title":"Randomized Placebo-Controlled Trial of Budesonide Multi-Matrix System (MMX®) 9 Milligrams (mg) in Participants With Ulcerative Colitis Currently on a 5-Aminosalicylic Acid (5-ASA)","status":"COMPLETED","sponsor":"Bausch Health Americas, Inc.","startDate":"2012-01-27","conditions":"Ulcerative Colitis","enrollment":510},{"nctId":"NCT04034758","phase":"NA","title":"Safety and Efficacy of Heterologous FMT by SQIMC-md Capsule in Mild-moderate Ulcerative Colitis Patients","status":"UNKNOWN","sponsor":"Tongji Hospital","startDate":"2019-08-30","conditions":"Ulcerative Colitis","enrollment":99},{"nctId":"NCT03070574","phase":"PHASE2","title":"Mesalamine for Colorectal Cancer Prevention Program in Lynch Syndrome","status":"TERMINATED","sponsor":"Christoph Gasche","startDate":"2017-11-24","conditions":"Colorectal Cancer","enrollment":8},{"nctId":"NCT03804931","phase":"PHASE2, PHASE3","title":"Fecal Microbiota Transplantation for Ulcerative Colitis","status":"RECRUITING","sponsor":"Guangzhou First People's Hospital","startDate":"2019-01-20","conditions":"Ulcerative Colitis, Fecal Microbiota Transplantation","enrollment":120},{"nctId":"NCT03625739","phase":"","title":"Population Pharmacokinetics of Anti-tuberculosis Drugs in Children With Tuberculosis","status":"RECRUITING","sponsor":"Beijing Children's Hospital","startDate":"2018-07-01","conditions":"Tuberculosis","enrollment":800},{"nctId":"NCT00495521","phase":"PHASE2","title":"High Dose Oral 4-Aminosalicylic Acid (PASER®) to Control Acute Flares of Mild to Moderate Crohn's Disease in Children","status":"TERMINATED","sponsor":"Jacobus Pharmaceutical","startDate":"2007-06","conditions":"Crohn's Disease","enrollment":2},{"nctId":"NCT02975570","phase":"PHASE3","title":"Efficacy and Tolerability of Delamanid, Linezolid, Pyrazinamide and Levofloxacin","status":"WITHDRAWN","sponsor":"Boston University","startDate":"2017-08","conditions":"Tuberculosis Multi Drug Resistant Active","enrollment":""},{"nctId":"NCT00514982","phase":"PHASE2","title":"Medical Treatment of Colitis in Patients With Hermansky-Pudlak Syndrome","status":"WITHDRAWN","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2007-08-07","conditions":"Hermanski-Pudlak Syndrome, Colitis, Cytokines","enrollment":""},{"nctId":"NCT00984568","phase":"PHASE3","title":"Conventional Step-Up Versus Infliximab Monotherapy in Patients With Ulcerative Colitis (P05553)","status":"TERMINATED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2009-11","conditions":"Colitis, Ulcerative","enrollment":28},{"nctId":"NCT03070405","phase":"PHASE1","title":"The Effect of PAS on the Pharmacokinetics of Tenofovir in Healthy Subjects","status":"UNKNOWN","sponsor":"Inje University","startDate":"2016-10","conditions":"Healthy Volunteers","enrollment":20},{"nctId":"NCT01577966","phase":"NA","title":"Pilot Study Effect of Sulfasalazine on Glutamate Levels by(Magnetic Resonance Spectroscopy)MRS in Patients With Glioma","status":"COMPLETED","sponsor":"University of Alabama at Birmingham","startDate":"2012-01","conditions":"Brain Tumor","enrollment":9},{"nctId":"NCT02077777","phase":"PHASE2","title":"Chemopreventive Action of Mesalazine on Colorectal Cancer: a Pilot Study for an \"in Vivo\" Evaluation of the Molecular Effects on β-catenin Signaling Pathway.","status":"COMPLETED","sponsor":"SOFAR S.p.A.","startDate":"2012-10","conditions":"Colorectal Cancer","enrollment":21},{"nctId":"NCT02683733","phase":"PHASE3","title":"Bio-enhanced Curcumin as an Add-On Treatment in Mild to Moderate Ulcerative Colitis","status":"UNKNOWN","sponsor":"Asian Institute of Gastroenterology, India","startDate":"2016-02","conditions":"Ulcerative Colitis","enrollment":50},{"nctId":"NCT01320436","phase":"PHASE3","title":"Curcumin + Aminosalicylic Acid (5ASA) Versus 5ASA Alone in the Treatment of Mild to Moderate Ulcerative Colitis","status":"COMPLETED","sponsor":"Sheba Medical Center","startDate":"2011-07","conditions":"Ulcerative Colitis","enrollment":50},{"nctId":"NCT00004423","phase":"NA","title":"Controlled Trial of 4-Aminosalicylic Acid in Patients With Small Bowel Crohn's Disease","status":"COMPLETED","sponsor":"University of Vermont","startDate":"1995-12","conditions":"Crohn's Disease","enrollment":80},{"nctId":"NCT01654783","phase":"","title":"Observational Study in the Management of Ulcerative Colitis With Oral 5-ASA","status":"COMPLETED","sponsor":"Kyorin Pharmaceutical Co.,Ltd","startDate":"2012-09","conditions":"Ulcerative Colitis","enrollment":5704},{"nctId":"NCT01090102","phase":"PHASE4","title":"Mesalamine to Reduce T Cell Activation in HIV Infection","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2010-06","conditions":"HIV Infections, Sexually Transmitted Diseases, Immune System Diseases","enrollment":33},{"nctId":"NCT02128308","phase":"PHASE1","title":"Clinical Trial to Investigate the Pharmacokinetics of Second-Line Anti-Tuberculosis Agents","status":"COMPLETED","sponsor":"Seoul National University Hospital","startDate":"2013-11","conditions":"Healthy","enrollment":16},{"nctId":"NCT01586533","phase":"PHASE2","title":"Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis","status":"UNKNOWN","sponsor":"Altheus Therapeutics, Inc.","startDate":"2012-06","conditions":"Ulcerative Colitis, Left-sided Ulcerative Colitis, Distal Ulcerative Colitis","enrollment":120},{"nctId":"NCT01860963","phase":"NA","title":"Anal Dysplasia in Patients With Inflammatory Bowel Disease and Healthy Controls","status":"COMPLETED","sponsor":"Stanford University","startDate":"2010-01","conditions":"Anal Squamous Intraepithelial Lesion (ASIL), HPV DNA","enrollment":310},{"nctId":"NCT01004185","phase":"PHASE3","title":"Assessing the Safety/Efficacy of Asacol® Given Every 12 Hours to Children and Adolescents for the Maintenance of Remission of Ulcerative Colitis","status":"TERMINATED","sponsor":"Warner Chilcott","startDate":"2009-10","conditions":"Ulcerative Colitis","enrollment":39},{"nctId":"NCT01020708","phase":"PHASE1","title":"Study of the Safety and Tolerability of ALTH12 Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis","status":"COMPLETED","sponsor":"Altheus Therapeutics, Inc.","startDate":"2009-11","conditions":"Ulcerative Colitis","enrollment":9},{"nctId":"NCT00417690","phase":"PHASE2","title":"High Dose Oral 4-Aminosalicylic Acid (PASER®) to Control Acute Flares of Mild to Moderate Crohn's Disease","status":"TERMINATED","sponsor":"Jacobus Pharmaceutical","startDate":"2007-01","conditions":"Crohn's Disease","enrollment":54},{"nctId":"NCT00513396","phase":"PHASE2, PHASE3","title":"High-Dose Isoniazid Adjuvant Therapy for Multidrug Resistant Tuberculosis","status":"COMPLETED","sponsor":"GSVM Medical College","startDate":"2004-01","conditions":"Tuberculosis, Multidrug-Resistant","enrollment":134},{"nctId":"NCT00069498","phase":"PHASE1","title":"Effect of an Anti-Inflammatory Drug on Gut Mucosa in HIV Infected Patients","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"1999-10","conditions":"HIV Infections","enrollment":14},{"nctId":"NCT00004810","phase":"PHASE2","title":"Phase II Placebo-Controlled Study of 4-Aminosalicylic Acid for Ulcerative Colitis","status":"COMPLETED","sponsor":"National Center for Research Resources (NCRR)","startDate":"1996-06","conditions":"Ulcerative Colitis","enrollment":30}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":2863,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["PAS"],"phase":"phase_3","status":"active","brandName":"Para-Aminosalicylic Acid","genericName":"Para-Aminosalicylic Acid","companyName":"Beijing Chest Hospital","companyId":"beijing-chest-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Para-Aminosalicylic Acid is a bacteriostatic antibiotic that inhibits the synthesis of folate in bacteria. Used for Tuberculosis.","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"EU","regulator":"EMA","status":"withdrawn","approval_date":null,"mah":null,"brand_name_local":"Granupas (previously Para-aminosalicylic acid Lucane)","application_number":"EMEA/H/C/002709"},{"country_code":"GB","regulator":"MHRA","status":"approved","approval_date":null,"mah":null,"brand_name_local":"Granupas (previously Para-aminosalicylic acid Lucane)","application_number":null}],"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}